Dry vs. Wet Macular Degeneration: Why the Difference Matters for Treatment

Age-related macular degeneration (AMD) comes in two distinct forms, and the difference between them isn’t just a matter of severity — it determines the entire treatment approach, monitoring schedule, and what to realistically expect going forward.

Dry AMD: The More Common, Slower-Progressing Form

Dry AMD accounts for the large majority of macular degeneration cases. It develops as the macula — the part of the retina responsible for sharp central vision — gradually thins over time, often with the accumulation of small deposits called drusen visible on examination.

Dry AMD typically progresses slowly, sometimes over many years, and in its early stages often causes no noticeable symptoms at all. This is exactly why regular dilated screening after age 50 matters, even when vision feels completely normal.

Management of dry AMD centers on regular monitoring, lifestyle modification — particularly smoking cessation and UV protection — and, for certain stages, specific vitamin and antioxidant supplementation that has been shown in clinical studies to slow progression.

Wet AMD: Less Common, But Faster and More Urgent

Wet AMD develops when abnormal new blood vessels grow beneath the retina and leak fluid or blood, distorting or damaging central vision. Unlike dry AMD’s gradual course, wet AMD can progress rapidly — sometimes causing significant vision changes within weeks.

Management of wet AMD centers on anti-VEGF injections, which work by suppressing this abnormal blood vessel growth and reducing leakage. Unlike dry AMD, where the focus is on slowing progression, treatment for wet AMD aims to actively control an active process — and the timeliness of starting treatment has a real impact on how much vision can be preserved.

Can Dry AMD Become Wet AMD?

Yes — dry AMD can convert to wet AMD at any stage, which is part of why regular monitoring matters even for patients whose dry AMD has been stable for years. This is also why any sudden change in vision — new distortion, a blank spot, or rapid worsening — in someone with known dry AMD should be evaluated promptly rather than assumed to be more of the same gradual progression.

Why Getting the Distinction Right Matters

A diagnosis of “macular degeneration” alone doesn’t tell you what to expect — whether dry or wet fundamentally changes the urgency, the treatment plan, and the monitoring schedule that follows. This is determined through a dilated retinal examination and OCT imaging, which is why precise diagnosis, not just a general label, is the foundation of appropriate AMD management.